|
Novel treatment options for early stage NSCLC |
01/09/2023 - 12:00pm to 1:00pm EST |
|
Triple Negative Breast Cancer |
02/06/2023 - 12:00pm to 1:00pm EST |
|
Management of locally advanced esophageal cancer |
02/13/2023 - 12:00pm to 1:00pm EST |
|
Core Binding Factor AML |
03/13/2023 - 12:00pm to 1:00pm EDT |
|
APML |
03/20/2023 - 12:00pm to 1:00pm EDT |
|
First Line Treatment of Hormone Receptor Positive Metastatic Breast Cancer |
03/27/2023 - 12:00pm to 1:00pm EDT |
|
Marginal Zone Lymphoma: Front-line treatment options |
04/10/2023 - 12:00pm to 1:00pm EDT |
|
Grade 3 IDH-wt Astrocytoma |
04/24/2023 - 12:00pm to 1:00pm EDT |
|
Small cell lung cancer second line and beyond |
05/08/2023 - 12:00pm to 1:00pm EDT |
|
TP53 mutated AML |
05/15/2023 - 12:00pm to 1:00pm EDT |